Literature DB >> 1880315

Glucocorticoid therapy for asthma: clinical pharmacology.

S J Szefler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1880315     DOI： 10.1016/0091-6749(91)90323-g

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  11 in total

1.  Effects of several glucocorticosteroids and PDE4 inhibitors on increases in total lung eosinophil peroxidase (EPO) levels following either systemic or intratracheal administration in sephadex- or ovalbumin-induced inflammatory models.

Authors:  D M Hammerbeck; S M McGurran; P L Radziszewski; E A Egging; D D Johnson; A M Hupperts; G W Gullikson
Journal:  Inflammation       Date:  2000-08       Impact factor: 4.092

Review 2.  New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future.

Authors:  V A Alabaster; B A Moore
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

3.  The efficacy of immediate diet for reducing local adverse events of inhaled corticosteroid: a pilot study.

Authors:  Myoung Kyu Lee; Won Yeon Lee; Suk Joong Yong; Kye Chul Shin; Chong Whan Kim; Ji-Ho Lee; Saehyun Jung; Ye-Ryung Jung; Hyun Sik Kim; Tae-Sun Yu; Sang-Ha Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-08-31

4.  A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.

Authors:  B Meibohm; G Hochhaus; H Möllmann; J Barth; M Wagner; M Krieg; R Stöckmann; H Derendorf
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

5.  Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Miroslawa Pietruczuk; Grzegorz Zalewski
Journal:  Pediatr Nephrol       Date:  2006-06-08       Impact factor: 3.714

Review 6.  Inhaled corticosteroids in children. Is there a 'safe' dosage?

Authors:  A L Boner; G L Piacentini
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

7.  Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

Authors:  E R Sher; D Y Leung; W Surs; J C Kam; G Zieg; A K Kamada; S J Szefler
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Assessment of pediatric asthma drug use in three European countries; a TEDDY study.

Authors:  Elif Fatma Sen; Katia M C Verhamme; Antje Neubert; Yingfen Hsia; Macey Murray; Mariagrazia Felisi; Carlo Giaquinto; Geert W 't Jong; Gino Picelli; Eugenio Baraldi; Alfredo Nicolosi; Adriana Ceci; Ian C Wong; Miriam C J M Sturkenboom
Journal:  Eur J Pediatr       Date:  2010-09-02       Impact factor: 3.183

Review 9.  Pharmacokinetic Drug-Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids.

Authors:  Edward T Van Matre; Gowri Satyanarayana; Robert L Page 2nd; Marilyn E Levi; JoAnn Lindenfeld; Scott W Mueller
Journal:  Ann Transplant       Date:  2018-01-23       Impact factor: 1.530

10.  Corticosteroid pharmacokinetic abnormalities in overweight and obese corticosteroid resistant asthmatics.

Authors:  Elena Goleva; Ronina Covar; Richard J Martin; Donald Y M Leung
Journal:  J Allergy Clin Immunol Pract       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.